Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Lumos Diagnostics.
RELATED STOCKHEAD STORIES
Stockhead TV
Road to 2025: How Lumos has diagnosed its place in the market
Health & Biotech
Health Check: Telix to acquire next-gen therapeutics and biologics platform
News
Closing Bell: ASX drops to three-month low, while CHESS system outage halts settlements
Health & Biotech
Lumos starts ‘pivotal clinical study’ in US for point-of-care respiratory test
News
Closing Bell: ASX rises on tech rally, Lumos gets US approval, and Bitcoin breaks through US$102k
Health & Biotech
US reimbursement rate set for Lumos point-of-care respiratory test
Health & Biotech
ASX health stocks fighting superbugs to save lives
Health & Biotech
ASX Quarterly Health Wrap: Lift-off for ED nasal spray and record users for pregnancy-monitoring platform
Health & Biotech
Health Check: Thirsty Chimeric goes to the well for funding top-up
Health & Biotech
ASX innovators reshaping traditional medical treatments
Stockhead TV
Long Shortz with Lumos Diagnostics: Attention from the globe as antimicrobial resistance takes flight
Health & Biotech
ASX medical disruptors pioneering new diagnostics and cutting-edge procedures
News
Closing Bell: Investors left high and dry after China disappoints; Iron ore, oil stocks swing to losses
Health & Biotech
Health Check: Lion City’s Orthocell approval provides a Singapore Sling-board to Asian markets
Health & Biotech
Lumos inks groundbreaking US funding deal to support critical study for point-of-care respiratory test
News
Closing Bell: Inflation cools, miners rally hard, and Fortescue leaps after going electric
Health & Biotech
